Page 859 - Read Online
P. 859

Page 16 of 17                                       Melillo et al. Mini-invasive Surg 2020;4:81  I  http://dx.doi.org/10.20517/2574-1225.2020.83

                   Echocardiography in Quantifying Mitral Regurgitation: A Comparison with Conventional Two-Dimensional Methods. J Am Soc
                   Echocardiogr 2017;30:393-403.
               5.   Nolan MT, Thavendiranathan P. Automated Quantification in Echocardiography. JACC Cardiovasc Imaging 2019;12:1073-92.
               6.   Dorosz JL, Lezotte DC, Weitzenkamp DA, Allen LA, Salcedo EE. Performance of 3-dimensional echocardiography in measuring left
                   ventricular volumes and ejection fraction: a systematic review and meta-analysis. J Am Coll Cardiol 2012;59:1799-808.
               7.   Papadopoulos K, Ikonomidis I, Chrissoheris M, et al. MitraClip and left ventricular reverse remodelling: a strain imaging study. ESC
                   Heart Fail 2020;7:1409-18.
               8.   Baumgartner H, Falk V, Bax JJ, et al; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular
                   heart disease. Eur Heart J 2017;38:2739-91.
               9.   Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from
                   the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am
                   Soc Echocardiogr 2017;30:303-71.
               10.  Zeng X, Levine RA, Hua L, et al. Diagnostic value of vena contracta area in the quantification of mitral regurgitation severity by color
                   Doppler 3D echocardiography. Circ Cardiovasc Imaging 2011;4:506-13.
               11.  Bartko PE, Arfsten H, Heitzinger G, et al. A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation. J Am
                   Coll Cardiol 2019;73:2506-17.
               12.  Lancellotti P, Magne J, Dulgheru R, Ancion A, Martinez C, Piérard LA. Clinical significance of exercise pulmonary hypertension in
                   secondary mitral regurgitation. Am J Cardiol 2015;115:1454-61.
               13.  Lancellotti P, Gérard PL, Piérard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur
                   Heart J 2005;26:1528-32.
               14.  Velu JF, Baan J Jr, de Bruin-Bon HACM, et al. Can stress echocardiography identify patients who will benefit from percutaneous mitral
                   valve repair? Int J Cardiovasc Imaging 2019;35:645-51.
               15.  Uretsky S, Argulian E, Narula J, Wolff SD. Use of Cardiac Magnetic Resonance Imaging in Assessing Mitral Regurgitation: Current
                   Evidence. J Am Coll Cardiol 2018;71:547-63.
               16.  Hundley WG, Li HF, Willard JE, et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with
                   invasive techniques. Circulation 1995;92:1151-8.
               17.  Uretsky S, Gillam L, Lang R, et al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a
                   prospective multicenter trial. J Am Coll Cardiol 2015;65:1078-88.
               18.  Fujita N, Chazouilleres AF, Hartiala JJ, et al. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance
                   imaging. Journal of the American College of Cardiology 1994;23:951-8.
               19.  Gelfand EV, Hughes S, Hauser TH, et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance:
                   optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson 2006;8:503-7.
               20.  Lopez-Mattei JC, Ibrahim H, Shaikh KA, et al. Comparative Assessment of Mitral Regurgitation Severity by Transthoracic
                   Echocardiography and Cardiac Magnetic Resonance Using an Integrative and Quantitative Approach. Am J Cardiol 2016;117:264-70.
               21.  Sachdev V, Hannoush H, Sidenko S, et al. Are Echocardiography and CMR Really Discordant in Mitral Regurgitation? JACC Cardiovasc
                   Imaging 2017;10:823-4.
               22.  Choi J, Heo R, Hong GR, et al. Differential effect of 3-dimensional color Doppler echocardiography for the quantification of mitral
                   regurgitation according to the severity and characteristics. Circ Cardiovasc Imaging 2014;7:535-44.
               23.  Thavendiranathan P, Liu S, Datta S, et al. Quantification of chronic functional mitral regurgitation by automated 3-dimensional peak
                   and integrated proximal isovelocity surface area and stroke volume techniques using real-time 3-dimensional volume color Doppler
                   echocardiography: in vitro and clinical validation. Circ Cardiovasc Imaging 2013;6:125-33.
               24.  Westenberg JJ, Roes SD, Marsan NA, et al. Mitral valve and tricuspid valve blood flow: accurate quantification with 3D velocity-encoded
                   MR imaging with retrospective valve tracking. Radiology 2008;249:792-800.
               25.  Garg P, Swift AJ, Zhong L, et al. Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging. Nat Rev
                   Cardiol 2020;17:298-312.
               26.  Myerson SG, d’Arcy J, Christiansen JP, et al. Determination of Clinical Outcome in Mitral Regurgitation With Cardiovascular Magnetic
                   Resonance Quantification. Circulation 2016;133:2287-96.
               27.  Penicka M, Vecera J, Mirica DC, Kotrc M, Kockova R, Camp GV. Prognostic Implications of Magnetic Resonance-Derived
                   Quantification in Asymptomatic Patients With Organic Mitral Regurgitation: Comparison With Doppler Echocardiography-Derived
                   Integrative Approach. Circulation 2018;137:1349-60.
               28.  Cavalcante JL, Kusunose K, Obuchowski NA, et al. Prognostic Impact of Ischemic Mitral Regurgitation Severity and Myocardial Infarct
                   Quantification by Cardiovascular Magnetic Resonance. JACC Cardiovasc Imaging 2020;13:1489-501.
               29.  Marra MP, Basso C, De Lazzari M, et al. Morphofunctional Abnormalities of Mitral Annulus and Arrhythmic Mitral Valve Prolapse. Circ
                   Cardiovasc Imaging 2016;9:e005030.
               30.  Miller MA, Dukkipati SR, Turagam M, Liao SL, Adams DH, Reddy VY. Arrhythmic mitral valve prolapse: JACC review topic of the
                   week. J Am Coll Cardiol 2018;72:2904-14.
               31.  Rowin EJ, Maron BJ, Maron MS. The hypertrophic cardiomyopathy phenotype viewed through the prism of multimodality imaging:
                   clinical and etiologic implications. JACC Cardiovasc Imaging 2020;13:2002-16.
               32.  Faggioni L, Gabelloni M, Accogli S, et al. Preprocedural planning of transcatheter mitral valve interventions by multidetector CT: what
                   the radiologist needs to know. Eur J Radiol Open 2018;5:131-40.
   854   855   856   857   858   859   860   861   862   863   864